Intranasal Oxytocin to Treat Mental Disorders: A Meta-Analysis of Randomized Controlled Trials

Poster Session VIII

Keyword: Psychopathology

Abstract: Intranasal oxytocin has received growing attention for its potential to improve the treatment of mental disorders. The current systematic review is the first to meta-analyze clinical outcomes across psychiatric diagnoses since 2013. Overall efficacy was null; meta-regressions will uncover key individual and contextual factors influencing oxytocin’s effects in clinical populations.

• Justin Bonnieux (Presenting Author)
• Kellie-Anne Bélisle (Author)
• Alexandra Harboun (Author)
• Alexandra Haddad (Author)
• Alison McLellan (Author)
• Leo Chester-Trudel (Author)
• Olivia Quintus-Bosz (Author)
• David Garred (Author)
• Florencia Trespalacios (Author)
• Tiffany Resendes (Author)
• Stephanie Gumuchian (Author)
• Mark Ellenbogen (Author)